BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 32507511)

  • 1. Neurodevelopmental Disorders: From Genetics to Functional Pathways.
    Parenti I; Rabaneda LG; Schoen H; Novarino G
    Trends Neurosci; 2020 Aug; 43(8):608-621. PubMed ID: 32507511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual research review: The (epi)genetics of neurodevelopmental disorders in the era of whole-genome sequencing--unveiling the dark matter.
    Kiser DP; Rivero O; Lesch KP
    J Child Psychol Psychiatry; 2015 Mar; 56(3):278-95. PubMed ID: 25677560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
    Prem S; Millonig JH; DiCicco-Bloom E
    Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maltreatment-associated neurodevelopmental disorders: a co-twin control analysis.
    Dinkler L; Lundström S; Gajwani R; Lichtenstein P; Gillberg C; Minnis H
    J Child Psychol Psychiatry; 2017 Jun; 58(6):691-701. PubMed ID: 28094432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted sequencing and integrative analysis to prioritize candidate genes in neurodevelopmental disorders.
    Zhang Y; Wang T; Wang Y; Xia K; Li J; Sun Z
    Mol Neurobiol; 2021 Aug; 58(8):3863-3873. PubMed ID: 33860439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and environmental modulation of neurodevelopmental disorders: Translational insights from labs to beds.
    Homberg JR; Kyzar EJ; Scattoni ML; Norton WH; Pittman J; Gaikwad S; Nguyen M; Poudel MK; Ullmann JF; Diamond DM; Kaluyeva AA; Parker MO; Brown RE; Song C; Gainetdinov RR; Gottesman II; Kalueff AV
    Brain Res Bull; 2016 Jul; 125():79-91. PubMed ID: 27113433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential Role of Microtubule Stabilizing Agents in Neurodevelopmental Disorders.
    Bonini SA; Mastinu A; Ferrari-Toninelli G; Memo M
    Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28933765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies for dissecting the complexity of neurodevelopmental disorders.
    Sun J; Noss S; Banerjee D; Das M; Girirajan S
    Trends Genet; 2024 Feb; 40(2):187-202. PubMed ID: 37949722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of big data and machine learning algorithms to extract possible treatment targets in neurodevelopmental disorders.
    Malik MA; Faraone SV; Michoel T; Haavik J
    Pharmacol Ther; 2023 Oct; 250():108530. PubMed ID: 37708996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chromatin basis of neurodevelopmental disorders: Rethinking dysfunction along the molecular and temporal axes.
    Gabriele M; Lopez Tobon A; D'Agostino G; Testa G
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt B):306-327. PubMed ID: 29309830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving treatment of neurodevelopmental disorders: recommendations based on preclinical studies.
    Homberg JR; Kyzar EJ; Stewart AM; Nguyen M; Poudel MK; Echevarria DJ; Collier AD; Gaikwad S; Klimenko VM; Norton W; Pittman J; Nakamura S; Koshiba M; Yamanouchi H; Apryatin SA; Scattoni ML; Diamond DM; Ullmann JF; Parker MO; Brown RE; Song C; Kalueff AV
    Expert Opin Drug Discov; 2016; 11(1):11-25. PubMed ID: 26558752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of sleep and circadian ontogeny through the lens of neurodevelopmental disorders.
    Barone I; Hawks-Mayer H; Lipton JO
    Neurobiol Learn Mem; 2019 Apr; 160():160-172. PubMed ID: 30668981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A molecular model for neurodevelopmental disorders.
    Gigek CO; Chen ES; Ota VK; Maussion G; Peng H; Vaillancourt K; Diallo AB; Lopez JP; Crapper L; Vasuta C; Chen GG; Ernst C
    Transl Psychiatry; 2015 May; 5(5):e565. PubMed ID: 25966365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the genetic basis of comorbid epilepsy phenotypes in neurodevelopmental disorders.
    Chow J; Jensen M; Amini H; Hormozdiari F; Penn O; Shifman S; Girirajan S; Hormozdiari F
    Genome Med; 2019 Oct; 11(1):65. PubMed ID: 31653223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare copy number variations affecting the synaptic gene DMXL2 in neurodevelopmental disorders.
    Costain G; Walker S; Argiropoulos B; Baribeau DA; Bassett AS; Boot E; Devriendt K; Kellam B; Marshall CR; Prasad A; Serrano MA; Stavropoulos DJ; Twede H; Vermeesch JR; Vorstman JAS; Scherer SW
    J Neurodev Disord; 2019 Feb; 11(1):3. PubMed ID: 30732576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversibility and therapeutic development for neurodevelopmental disorders, insights from genetic animal models.
    Megagiannis P; Suresh R; Rouleau GA; Zhou Y
    Adv Drug Deliv Rev; 2022 Dec; 191():114562. PubMed ID: 36183904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ISWI chromatin remodeling complexes in brain development and neurodevelopmental disorders.
    Goodwin LR; Picketts DJ
    Mol Cell Neurosci; 2018 Mar; 87():55-64. PubMed ID: 29249292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene Transfer Therapy for Neurodevelopmental Disorders.
    Ozlu C; Bailey RM; Sinnett S; Goodspeed KD
    Dev Neurosci; 2021; 43(3-4):230-240. PubMed ID: 33882495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopmental disorders, like cancer, are connected to impaired chromatin remodelers, PI3K/mTOR, and PAK1-regulated MAPK.
    Nussinov R; Yavuz BR; Arici MK; Demirel HC; Zhang M; Liu Y; Tsai CJ; Jang H; Tuncbag N
    Biophys Rev; 2023 Apr; 15(2):163-181. PubMed ID: 37124926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Essential genetic findings in neurodevelopmental disorders.
    Cardoso AR; Lopes-Marques M; Silva RM; Serrano C; Amorim A; Prata MJ; Azevedo L
    Hum Genomics; 2019 Jul; 13(1):31. PubMed ID: 31288856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.